Antibacterial effect of squid ink on ESBL producing strains of Escherichia coli and Klebsiella pneumoniae

Indian Journal of Marine Sciences

Volumn 41, Issue 4, 2012, Pages 338-343

  Girija Smiline, A S ^a   Vijayshree Priyadharshini, J ^a   Pandi Suba, K ^a   Hariprasad, P ^a   Raguraman, R ^a  

^a MEENAKSHI AMMAL DENTAL COLLEGE AND HOSPITAL   (India)

Author keywords

Antibacterial activity; E.coli; ESBL; Klebsiella; Squid ink

Indexed keywords

ANTIMICROBIAL ACTIVITY; BIOTECHNOLOGY; CEPHALOPOD; DISEASE TREATMENT; FECAL COLIFORM; MARINE TECHNOLOGY; MEDICINE; PIGMENT; PUBLIC HEALTH; BACTERIAL DISEASE; BACTERIUM; METABOLITE; PERCIFORM; SECRETION;

CEPHALOPODA; ESCHERICHIA COLI; KLEBSIELLA; KLEBSIELLA PNEUMONIAE;

EID: 84865324552     PISSN: 03795136     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Cosgrove, S.E., The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay and health care costs, Clin Infect Dis 42 (2006) 82-89.
2. Schwaber, M.J., Carmeli, Y., Antimicrobial resistance and patient outcomes: the hazards of adjustment, Crit Care 10 (5) (2006) 164.
3. Roy, C., Sergua, C., Tirado, M.R., Reig, M., Tervel, D., Frequency of plasmid determined beta-lactamases in 680 consecutively isolated strains of Enterobacteriaceae, Eur J Clin Microbiol Infec Dis 4 (1986) 146-147.
4. DuBois, S. K., Marriott, M. S., Amyes, S.G., TEM and SHV derived extended spectrum b-lactamases: relationship between selection, structure, and function, J Antimicrob Chemother 35 (1995) 7-32.
5. Jacoby, G.A., Carreras, I., Activities of β-lactam antibiotics against Escherichia coli strains producing extended-spectrum β-lactamases, Antimicrob Agents Chemother 34 (1990) 858-862.
6. Moland, E.S., Thompson, K.S., Extended-spectrum _-lactamases of Enterobacteriaceae, J Antimicrob Chemother 33 (1994) 666-668.
7. Tenover, F.C., Mohammed, M.J., Gorton, T.S., Dembek, Z.F., Detection and reporting of organisms producing extended-spectrum β-lactamases: Survey of laboratories in Connecticut, J Clin Microbiol 37 (1999) 4065-4070.
8. McConnell, O., Longley, R.E., Koehn, F.E., Gullo, V.P., The discovery of natural products with therapeutic potential, Butterworth-Heinemann Bos, (1994) 109-174.
9. Santhana Ramasamy, M., Murugan, A., Potential antimicrobial activity of marine mollusks from Tuticorin, southeast coast of India against 40 biofilm bacteria, J Shellfish Res 24 (2005) 243-251.
10. Atushi Mochizuki., An antiseptic effect of cuttlefish ink, Bull of the Jap Soc of Sci Fisheries 45(11)(1979) 1401-1403.
11. Edward, G., Ruby Margaret, J., McFall-Ngai., Oxygenutilizing reactions and symbiotic colonization of the squid light organ by Vibrio fischeri, Trends in Microbiology 7 (10) (1999) 966-972.
12. Takai, M., Kawai, Y., Inoue, N., Shinano, H., Cepahalopod ink-bioactivity, Bull Japanese Soc Sci Fisheries 58 (1992) 2373-2378.
13. Lei, M., Wang, J.F., Pang, L., Wang, Y.M., Chen, S.G., Xue, C.H., Effects of sepia on the metabolization of blood lipid and antioxidant ability in hyperlipidemia rats, Chin J Mar Drugs 3 (2007) 30-33.
14. Rajaganapathy, J., Thyagarajan, S.P., Edward, J.K., Study on the cephalopod's ink for anti-retroviral activity, Ind J Exp Biol 38 (5) (2000) 519-20.
15. Ditty Chacko., Jamila Patterson., Effect of Pharaoh's cuttlefish Sepia pharaonis ink against bacterial pathogens, Ind J of Microbiol 45 (3) (2005) 223-226.
16. Benson, H.J., Microbiological Applications: Laboratory Manual in General Microbiology, McGraw Hill Pub, USA, (2004).
17. Bauer, A.W., Kirby, W.M., Sherris, J.C., Turck, M., Antibiotic susceptibility testing by a standardized single disc method, Am J Clin Pathol 45 (1966) 493-496.
18. Jarlier, V., Nicholas, M.H., Fournier, G., Philippon, A., Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns., Rev of Inf Dis 10 (1998) 867-78.
19. Zhou, A., Jiang, X., Xu, X., Improved alkaline lysis method for rapid isolation of plasmid DNA, Biotechniques 23 (1997) 592-594.
20. Nathan, P., Law, E.J. Murphy, D.F., A laboratory method for the selection of topical antimicrobial agents, Burns 4 (1978) 177-178.
21. McGinnis., Ronalde, M.G., Lorian, V., Williams., Antibiotic in Laboratory Medicine, 4th Edition, Baltimore (1996) 176-211.
22. Nkere, C.K., Iroegbu, C., Antibacterial screening of the root, stem and stembark extracts of Picralima nitida., Afri J of Biotech 4 (6) (2005) 522-526.
23. Rios, J.L., Recio, M.C., Villar, A., Screening methods for natural products with antimicrobial activity: a review of the literature. J Ethnopharmacol leaflets 23 (1988) 127-149.
24. Livermore, D.M., Brown, F.J., Detection of β-lactamasemediated resistance, J Antimicrob Chemother 48 (2001) 59-64.
25. Winokur, P.L., Canton, R., Casellas, J.M., Legakis, N., Variations in the prevalence of strains expressing an extended spectrum β-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region, Clin Inf Dis 32 (2001) 94-103.
26. Singh, N.P., Goyal, R., Changing trends in bacteriology of burns in the burns unit, Delhi, Burns 29 (2) (2003) 129-132.
27. Grover, S.S., Sharma, M., Chattopadhya., Kapoor., Phenotypic and genotyping detection of ESBL mediated cephalosporin resistance in Klebsiella pneumonia, J Inf 54 (2006) 279-288.
28. Palumbo, A., Melanogenesis in the ink gland of Sepia, Pig Cell Res 16 (2003) 333-334.
29. Prota, G., Melanins, melanocytes, melanogenesis: an illustrated history of the past half century, Pig Cell Res 13 (2000) 283-293.
30. Takaya, Y., Uchisawa, H., Matsue, H., Okusaki, B., An investigation of the antitumour peptide form squid ink, Biol Pharm Bull 17 (1994) 846-849.
31. Gomathi, N., Nair, P., Sherif., Antibacterial activity in the accessory nidamental gland extracts of the Indian squid Loligo duvauceli orbigny, Ind J of Mar Sci 39 (1) (2010) 100-104.
32. Ram kumar, R., Senthil Kumar, S., Patterson, J.K., Antibacterial activity of the epidermal layer of coral associated fishes of Tuticorin coast, Ind J Fish 52 (1) (2005) 119-124.
33. World Health Organisation (WHO), Use of antimicrobials outside human medicine and resultant antimicrobial resistance in humans, Report (2002).